| year | 2024Latest | 2023 |
|---|---|---|
Revenue | 0 € | 0 € |
Profit | 0 € | 0 € |
Assets | - | - |
Liabilities | - | - |
Equity | 100 € | - |
Employees | - | - |
Overall rating | B+75/100 |
Financial health | 70/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity |
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 3 years | - | 0% | |
Profit |
| Description | Registered |
|---|---|
| CEO (Male) |
| 60/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| 0,00 € |
- |
0% |
Equity | 100,00 € | - | 10% |
MB Imunolab is located at Trakų r. sav., Aukštadvario sen., Drabužininkų k., Angelų g. 5, LT-21281, LT-LT-21281.
The shareholders of MB Imunolab include 1 Lithuanian legal entities. View ownership details →
No, MB Imunolab does not have an active VAT number and is not registered as a VAT payer.
MB Imunolab was founded on October 30, 2023. The company has been operating for 3 years.
Annual financial report for 2024.
Annual financial report for 2023.
Registered in the Lithuanian register of legal entities.